Home » Topics » BioWorld Science

BioWorld Science
RSS

Recruitment starts in phase II study of DUR-928 in COVID-19 with acute liver or kidney injury

July 2, 2020

Early positive data for BNT-162b1 vaccine candidate against SARS-CoV-2

July 2, 2020

FDA clears initiation of phase III trial of siltuximab for COVID-19-associated ARDS

July 2, 2020

Menarini plans phase Ib/II study of MEN-1611 in metastatic colorectal cancer

July 2, 2020

Phase I study of DS-1062 expanded to include patients with TNBC

July 2, 2020

FDA approves IND for phase II study of antroquinonol in patients with COVID-19

July 2, 2020

Emerald Health Biotechnology Espana identifies monoglyceride lipase inhibitors

July 2, 2020

Dual CACNA2D1/mu-opioid receptor ligands discovered at Esteve

July 2, 2020

Lynk Pharmaceuticals patents Janus kinase inhibitors

July 2, 2020

New gamma-secretase inhibitors identified at Roche

July 2, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...